Back to Search
MARY DEMBSKI, PHARMD
PHARMD
Pharmacist
NPI: 1114553583Individual
Specialties, Licenses & Credentials
Research & Publications (5)
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
PMID 17090671·Proc Natl Acad Sci U S A·2006
7-preclinical
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
PMID 16854066·J Med Chem·2006
7-preclinical
Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells.
PMID 16126724·J Biol Chem·2005
7-preclinical
Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance.
PMID 12777378·J Biol Chem·2003
7-preclinical
Identification of leptin-induced transcripts in the mouse hypothalamus.
PMID 10969827·Diabetes·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 260 POLARIS PKWY
WESTERVILLE, OH 43082 - Phone
- (614) 533-3535
Quick Facts
- NPI
- 1114553583
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile